Published 7 days ago • loading... • Updated 7 days ago

Pharmaceutical Economics Column: Exploring the Economics of Medications (Part 142)Potentially Inappropriate Prescribing in Ireland

Summary by Mric-Global

Tetsuya Tanimoto, M.D.Medical Governance Research Institute, Tokyo, JapanIn spring 2023, our pharmaceutical conflicts of interest research group participated in an international conference in Bath, UK. There, we had the pleasure of meeting Professor Tom Fahey from the Royal College of Surgeons in Ireland.While Ireland is a small nation with an estimated population of 5.28 million in 2023, it boasts a young demographic and impressive economic met…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

Cannabis News World

Australian Medical Association Alleges distressing incidents of patient harm” in South Australia, specifically due to “inappropriate prescribing practices”. But Does Not Say Who Where What - Cannabis News World

Information supplied by Google generative AI The AMA is continuing its state-by-state critique of the medicinal cannabis industry, citing concerns about “distressing incidents of patient harm” in South Australia, specifically due to “inappropriate prescribing practices”. Here’s a more detailed breakdown: AMA’s Concerns: The Australian Medical Association (AMA) has publicly expressed concerns about the medicinal

7 days ago

Read Full Article